175 related articles for article (PubMed ID: 8708730)
1. Comparative cytotoxicity of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia.
Ito C; Evans WE; McNinch L; Coustan-Smith E; Mahmoud H; Pui CH; Campana D
J Clin Oncol; 1996 Aug; 14(8):2370-6. PubMed ID: 8708730
[TBL] [Abstract][Full Text] [Related]
2. Combination of prednisolone and low dosed dexamethasone exhibits greater in vitro antileukemic activity than equiactive dose of prednisolone and overcomes prednisolone drug resistance in acute childhood lymphoblastic leukemia.
Spenerova M; Dzubak P; Srovnal J; Radova L; Burianova R; Konecny P; Salkova S; Novak Z; Pospisilova D; Stary J; Blazek B; Hak J; Votava T; Timr P; Kaiserova E; Bubanska E; Mihal V; Hajduch M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Sep; 158(3):422-7. PubMed ID: 23128824
[TBL] [Abstract][Full Text] [Related]
3. In vitro cytotoxicity of docetaxel in childhood acute leukemias.
Consolini R; Pui CH; Behm FG; Raimondi SC; Campana D
J Clin Oncol; 1998 Mar; 16(3):907-13. PubMed ID: 9508172
[TBL] [Abstract][Full Text] [Related]
4. Stroma-supported immunocytometric assay (SIA): a novel method for testing the sensitivity of acute lymphoblastic leukemia cells to cytotoxic drugs.
Campana D; Manabe A; Evans WE
Leukemia; 1993 Mar; 7(3):482-8. PubMed ID: 7680404
[TBL] [Abstract][Full Text] [Related]
5. Use of stroma-supported cultures of leukemic cells to assess antileukemic drugs. I. Cytotoxicity of interferon alpha in acute lymphoblastic leukemia.
Manabe A; Yi T; Kumagai M; Campana D
Leukemia; 1993 Dec; 7(12):1990-5. PubMed ID: 8255098
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the antileukemic activity in vitro of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia.
Kaspers GJ; Veerman AJ; Popp-Snijders C; Lomecky M; Van Zantwijk CH; Swinkels LM; Van Wering ER; Pieters R
Med Pediatr Oncol; 1996 Aug; 27(2):114-21. PubMed ID: 8649318
[TBL] [Abstract][Full Text] [Related]
7. Use of stroma-supported cultures of leukemic cells to assess antileukemic drugs. II. Potent cytotoxicity of 2-chloro-deoxyadenosine in acute lymphoblastic leukemia.
Kumagai M; Manabe A; Coustan-Smith E; Blakley RL; Beck WT; Santana VM; Behm FG; Raimondi SC; Campana D
Leukemia; 1994 Jul; 8(7):1116-23. PubMed ID: 7913512
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity of cortivazol in childhood acute lymphoblastic leukemia.
Styczynski J; Kurylak A; Wysocki M
Anticancer Res; 2005; 25(3B):2253-8. PubMed ID: 16158972
[TBL] [Abstract][Full Text] [Related]
9. Short-term effects on linear growth and bone turnover in children randomized to receive prednisolone or dexamethasone.
Ahmed SF; Tucker P; Mushtaq T; Wallace AM; Williams DM; Hughes IA
Clin Endocrinol (Oxf); 2002 Aug; 57(2):185-91. PubMed ID: 12153596
[TBL] [Abstract][Full Text] [Related]
10. No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia.
van Beek RD; de Muinck Keizer-Schrama SM; Hakvoort-Cammel FG; van der Sluis IM; Krenning EP; Pieters R; van den Heuvel-Eibrink MM
Pediatr Blood Cancer; 2006 Jan; 46(1):88-93. PubMed ID: 15926166
[TBL] [Abstract][Full Text] [Related]
11. BCL-2 expression in childhood leukemia versus spontaneous apoptosis, drug induced apoptosis, and in vitro drug resistance.
Haarman EG; Kaspers GJ; Pieters R; van Zantwijk CH; Broekema GJ; Hählen K; Veerman AJ
Adv Exp Med Biol; 1999; 457():325-33. PubMed ID: 10500808
[TBL] [Abstract][Full Text] [Related]
12. Circumvention of glucocorticoid resistance in childhood leukemia.
Haarman EG; Kaspers GJ; Pieters R; Rottier MM; Veerman AJ
Leuk Res; 2008 Sep; 32(9):1417-23. PubMed ID: 18395253
[TBL] [Abstract][Full Text] [Related]
13. Clinical relevance of BCL-2 overexpression in childhood acute lymphoblastic leukemia.
Coustan-Smith E; Kitanaka A; Pui CH; McNinch L; Evans WE; Raimondi SC; Behm FG; Aricò M; Campana D
Blood; 1996 Feb; 87(3):1140-6. PubMed ID: 8562940
[TBL] [Abstract][Full Text] [Related]
14. Human B-cell progenitors and bone marrow microenvironment.
Campana D; Coustan-Smith E; Manabe A; Kumagai M; Murti KG; Silvennoinen O; Nishigaki H; Kitanaka A; Ito C
Hum Cell; 1996 Dec; 9(4):317-22. PubMed ID: 9183664
[TBL] [Abstract][Full Text] [Related]
15. The synthetic glucocorticoids prednisolone and dexamethasone regulate the same genes in acute lymphoblastic leukemia cells.
Bindreither D; Ecker S; Gschirr B; Kofler A; Kofler R; Rainer J
BMC Genomics; 2014 Aug; 15(1):662. PubMed ID: 25103118
[TBL] [Abstract][Full Text] [Related]
16. Biological characteristics and prognostic value of in vitro three-drug resistance to prednisolone, L-asparaginase, and vincristine in childhood acute lymphoblastic leukemia.
Hongo T; Yamada S; Yajima S; Watanabe C; Fujii Y; Kawasaki H; Yazaki M; Hanada R; Horikoshi Y
Int J Hematol; 1999 Dec; 70(4):268-77. PubMed ID: 10643153
[TBL] [Abstract][Full Text] [Related]
17. Different cellular drug resistance profiles in childhood lymphoblastic and non-lymphoblastic leukemia: a preliminary report.
Kaspers GJ; Kardos G; Pieters R; Van Zantwijk CH; Klumper E; Hählen K; de Waal FC; van Wering ER; Veerman AJ
Leukemia; 1994 Jul; 8(7):1224-9. PubMed ID: 8035616
[TBL] [Abstract][Full Text] [Related]
18. Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial.
Mitchell CD; Richards SM; Kinsey SE; Lilleyman J; Vora A; Eden TO;
Br J Haematol; 2005 Jun; 129(6):734-45. PubMed ID: 15952999
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporin A induces apoptosis in childhood acute lymphoblastic leukemia cells.
Ito C; Ribeiro RC; Behm FG; Raimondi SC; Pui CH; Campana D
Blood; 1998 Feb; 91(3):1001-7. PubMed ID: 9446662
[TBL] [Abstract][Full Text] [Related]
20. Migration of acute lymphoblastic leukemia cells into human bone marrow stroma.
Makrynikola V; Bianchi A; Bradstock K; Gottlieb D; Hewson J
Leukemia; 1994 Oct; 8(10):1734-43. PubMed ID: 7523799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]